Benefits of combining prevalent and incident cohorts: An application to myotonic dystrophy

Abstract

It is frequently of interest to estimate the time that individuals survive with a disease, that is, to estimate the time between disease onset and occurrence of a clinical endpoint such as death. Epidemiologic survival data are commonly collected from either an incident cohort, whose members' disease onset occurs after the study baseline date, or from a cohort with prevalent disease that is followed forward in time. Incident cohort survival data are limited by study termination, while prevalent cohort data provide biased (left-truncated) survival data. In this article, we investigate the advantages of a study design featuring simultaneous follow-up of prevalent and incident cohorts to the estimation of the survivor function. Our analyses are supported by simulations and illustrated using data on survival after myotonic dystrophy diagnosis from the United Kingdom Clinical Practice Research Datalink (CPRD). We demonstrate that the NPMLE using combined incident and prevalent cohort data estimates the true survivor function very well, even for moderate sample sizes, and ameliorates the disadvantages of using a purely incident or prevalent cohort.

Keywords

Canadian longitudinal study on aging delayed entry incident cohort left truncation prevalent cohort myotonic dystrophy survival analysis UK clinical practice research datalink

Get full access to this article

View all access options for this article.

References

Wang

M-C

. Nonparametric estimation from cross-sectional survival data. J Am Stat Assoc 1991; 86: 130–143.

Lynden-Bell

. A Method of allowing for known observational selection in small samples applied to 3CR quasars. Monthly Noticies Royal Astronom Soc 1971; 155: 95–118.

Tsai

W-Y

Jewell

Wang

M-C

. A note on the product-limit estimator under right censoring and left truncation. Biometrika 1987; 74: 883.

Pan

Chappell

. A nonparametric estimator of survival functions for arbitrarily truncated and censored data. Lifetime Data Analys 1998; 4: 187–202.

Tsai

W-Y

. Estimation of the survival function with increasing failure rate based on left truncated and right censored data. Biometrika 1988; 75: 319–324.

Woodroofe

. Estimating a distribution function with truncated data. Ann Stat 1985; 13: 163–177.

Pan

Chappell

. A note on inconsistency of NPMLE of the distribution function from left truncated and Case I interval censored data. Lifetime Data Analys 1999; 5: 197–202.

Wang

Pfeiffer

Alsaggaf

, et al. Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink. Int J Cancer 2018; 142: 1174–1181.

Raina

Wolfson

Kirkland

, et al. The Canadian longitudinal study on aging (CLSA). Can J Aging 2009; 28: 221–229.

10.

Vardi

. Empirical distributions in selection bias models. Ann Stat 1985; 13: 178–203.

11.

Laslett

. The survival curve under monotone density constraints with applications to two-dimensional line segment processes. Biometrika 1982; 69: 153–160.

12.

Van Zwet

. Laslett's line segment problem. Bernoulli 2004; 10: 377–396.

13.

Saarela

Kulathinal

Karvanen

. Joint analysis of prevalence and incidence data using conditional likelihood. Biostatistics 2009; 10: 575–587.

14.

Lai

Ying

. Estimating a distribution function with truncated and censored data. Ann Stat 1991; 19: 417–442.

15.

Gijbels

Wang

. Strong representations of the survival function estimator for truncated and censored data with applications. J Multivariate Analys 1993; 47: 210–229.

16.

Chao

M-T

S-H

. Some representations of the nonparametric maximum likelihood estimators with truncated data. Ann Stat 1988; 16: 661–668.

17.

Gross

Lai

. Bootstrap methods for truncated and censored data. Stat Sinica 1996; 6: 509–530.

18.

Udd

Krahe

. The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol 2012; 11: 891–905.

19.

Herrett

Gallagher

Bhaskaran

, et al. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol 2015; 44: 827–836.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.10 MB